MN 553 UNIT 5 QUIZ – QUESTION AND ANSWERS
point
Elderly patients who are started on levothyroxine for thyroid
replacement should be monitored for:
Question options:
ation
nd angina
ce
Potentially fatal granulocytopenia has been associated with
treatment of hyperthyroidism with propylthiouracil. Patients
should be taught to report:
Question options:
decreased salivation
e throat
a and osteoporosis
ma and difficulty swallowing
Metformin is a primary choice of drug to treat hyperglycemia
in type 2 diabetes because it:
Question options:
r insulin usually secreted by the pancreas
cogenolysis by the liver
release of insulin from beta cells
ipheral glucose utilization
Hypoglycemia can result from the action of either insulin or an
oral hypoglycemic. Signs and symptoms of hypoglycemia
include:
Question options:
,h odor and rapid respiration
ominal pain, weight loss, and hypertension
nfusion, diaphoresis, and tachycardia
palpitations, cardiac dysrhythmias, and coma
Sulfonylureas may be added to a treatment regimen for type 2
diabetics when lifestyle modifications and metformin are
insufficient to achieve target glucose levels. Sulfonylureas
have been moved to Step 2 therapy because they:
Question options:
genous insulin secretion
cant risk for hypoglycemia
nsulin resistance found in type 2 diabetics
in binding to receptors
Treatment with insulin for type 1 diabetics:
Question options:
otal daily dose of 0.2 to 0.4 units per kg of body weight
tal doses into three injections based on meal size
aily dose of insulin glargine given once daily with no other insulin required
e level of blood glucose
The American Heart Association states that people with
diabetes have a 2- to 4-fold increase in the risk of dying from
cardiovascular disease. Treatments and targets that do not
appear to decrease risk for micro- and macro-vascular
complications include:
Question options:
ets between 7% and 7.5%
in type 2 diabetics
pertension and hyperlipidemia
king
point
Elderly patients who are started on levothyroxine for thyroid
replacement should be monitored for:
Question options:
ation
nd angina
ce
Potentially fatal granulocytopenia has been associated with
treatment of hyperthyroidism with propylthiouracil. Patients
should be taught to report:
Question options:
decreased salivation
e throat
a and osteoporosis
ma and difficulty swallowing
Metformin is a primary choice of drug to treat hyperglycemia
in type 2 diabetes because it:
Question options:
r insulin usually secreted by the pancreas
cogenolysis by the liver
release of insulin from beta cells
ipheral glucose utilization
Hypoglycemia can result from the action of either insulin or an
oral hypoglycemic. Signs and symptoms of hypoglycemia
include:
Question options:
,h odor and rapid respiration
ominal pain, weight loss, and hypertension
nfusion, diaphoresis, and tachycardia
palpitations, cardiac dysrhythmias, and coma
Sulfonylureas may be added to a treatment regimen for type 2
diabetics when lifestyle modifications and metformin are
insufficient to achieve target glucose levels. Sulfonylureas
have been moved to Step 2 therapy because they:
Question options:
genous insulin secretion
cant risk for hypoglycemia
nsulin resistance found in type 2 diabetics
in binding to receptors
Treatment with insulin for type 1 diabetics:
Question options:
otal daily dose of 0.2 to 0.4 units per kg of body weight
tal doses into three injections based on meal size
aily dose of insulin glargine given once daily with no other insulin required
e level of blood glucose
The American Heart Association states that people with
diabetes have a 2- to 4-fold increase in the risk of dying from
cardiovascular disease. Treatments and targets that do not
appear to decrease risk for micro- and macro-vascular
complications include:
Question options:
ets between 7% and 7.5%
in type 2 diabetics
pertension and hyperlipidemia
king
